Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial
Marina Harutyunyan, Jens P Gøtze, Per Winkel, Julia S Johansen, Jørgen Fischer Hansen, Gorm Boje Jensen, Jørgen Hilden, Erik Kjøller, Hans J Kolmos, Christian Gluud, Jens Kastrup
Dive into the research topics of 'Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial'. Together they form a unique fingerprint.